EDTXF
Price
$0.35
Change
-$0.03 (-7.89%)
Updated
Jan 16 closing price
Capitalization
68.29M
67 days until earnings call
TDSGF
Price
$0.08
Change
-$0.01 (-11.11%)
Updated
Jan 17 closing price
Capitalization
13.15M
Ad is loading...

EDTXF vs TDSGF

Header iconEDTXF vs TDSGF Comparison
Open Charts EDTXF vs TDSGFBanner chart's image
Spectral Medical
Price$0.35
Change-$0.03 (-7.89%)
Volume$1.95K
Capitalization68.29M
Telo Genomics
Price$0.08
Change-$0.01 (-11.11%)
Volume$15.82K
Capitalization13.15M
EDTXF vs TDSGF Comparison Chart
Loading...
EDTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TDSGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDTXF vs. TDSGF commentary
Jan 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDTXF is a Hold and TDSGF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 20, 2025
Stock price -- (EDTXF: $0.35 vs. TDSGF: $0.08)
Brand notoriety: EDTXF and TDSGF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EDTXF: 18% vs. TDSGF: 84%
Market capitalization -- EDTXF: $68.29M vs. TDSGF: $13.15M
EDTXF [@Medical Specialties] is valued at $68.29M. TDSGF’s [@Medical Specialties] market capitalization is $13.15M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDTXF’s FA Score shows that 0 FA rating(s) are green whileTDSGF’s FA Score has 0 green FA rating(s).

  • EDTXF’s FA Score: 0 green, 5 red.
  • TDSGF’s FA Score: 0 green, 5 red.
According to our system of comparison, EDTXF is a better buy in the long-term than TDSGF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDTXF’s TA Score shows that 4 TA indicator(s) are bullish while TDSGF’s TA Score has 2 bullish TA indicator(s).

  • EDTXF’s TA Score: 4 bullish, 5 bearish.
  • TDSGF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, both EDTXF and TDSGF are a bad buy in the short-term.

Price Growth

EDTXF (@Medical Specialties) experienced а -11.24% price change this week, while TDSGF (@Medical Specialties) price change was -8.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

EDTXF is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDTXF($68.3M) has a higher market cap than TDSGF($13.2M). EDTXF YTD gains are higher at: -0.471 vs. TDSGF (-6.111). TDSGF has higher annual earnings (EBITDA): -2.59M vs. EDTXF (-8.81M). EDTXF has more cash in the bank: 4.89M vs. TDSGF (721K). TDSGF has less debt than EDTXF: TDSGF (40K) vs EDTXF (6.64M). EDTXF has higher revenues than TDSGF: EDTXF (1.71M) vs TDSGF (0).
EDTXFTDSGFEDTXF / TDSGF
Capitalization68.3M13.2M517%
EBITDA-8.81M-2.59M341%
Gain YTD-0.471-6.1118%
P/E RatioN/AN/A-
Revenue1.71M0-
Total Cash4.89M721K678%
Total Debt6.64M40K16,590%
FUNDAMENTALS RATINGS
EDTXF vs TDSGF: Fundamental Ratings
EDTXF
TDSGF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5962
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
26n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDTXF's Valuation (65) in the null industry is in the same range as TDSGF (86). This means that EDTXF’s stock grew similarly to TDSGF’s over the last 12 months.

EDTXF's Profit vs Risk Rating (100) in the null industry is in the same range as TDSGF (100). This means that EDTXF’s stock grew similarly to TDSGF’s over the last 12 months.

EDTXF's SMR Rating (100) in the null industry is in the same range as TDSGF (100). This means that EDTXF’s stock grew similarly to TDSGF’s over the last 12 months.

EDTXF's Price Growth Rating (59) in the null industry is in the same range as TDSGF (62). This means that EDTXF’s stock grew similarly to TDSGF’s over the last 12 months.

EDTXF's P/E Growth Rating (100) in the null industry is in the same range as TDSGF (100). This means that EDTXF’s stock grew similarly to TDSGF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDTXFTDSGF
RSI
ODDS (%)
Bearish Trend 12 days ago
78%
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
65%
Bearish Trend 12 days ago
88%
MACD
ODDS (%)
Bullish Trend 12 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
66%
Bullish Trend 12 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
71%
Bullish Trend 12 days ago
75%
Advances
ODDS (%)
Bullish Trend 14 days ago
69%
Bullish Trend 24 days ago
73%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 12 days ago
85%
View a ticker or compare two or three
Ad is loading...
EDTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TDSGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGIFX35.570.24
+0.68%
Steward Global Equity Income Fund C
MNCEX10.310.07
+0.68%
Mercer Non-US Core Equity Y3
JVSNX16.150.09
+0.56%
Janus Henderson Small-Mid Cap Value N
GEMRX13.240.06
+0.46%
abrdn Emerging Markets R
FIFAX24.870.11
+0.44%
American Funds Income Fund of Amer F3

EDTXF and

Correlation & Price change

A.I.dvisor tells us that EDTXF and ASAPF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDTXF and ASAPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDTXF
1D Price
Change %
EDTXF100%
N/A
ASAPF - EDTXF
22%
Poorly correlated
N/A
KSRBF - EDTXF
21%
Poorly correlated
N/A
TDSGF - EDTXF
20%
Poorly correlated
-8.67%
FSPKF - EDTXF
3%
Poorly correlated
N/A
DSRLF - EDTXF
3%
Poorly correlated
N/A
More

TDSGF and

Correlation & Price change

A.I.dvisor tells us that TDSGF and OPK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TDSGF and OPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TDSGF
1D Price
Change %
TDSGF100%
-8.67%
OPK - TDSGF
24%
Poorly correlated
N/A
PRPO - TDSGF
22%
Poorly correlated
+5.85%
EDTXF - TDSGF
20%
Poorly correlated
N/A
USAQ - TDSGF
10%
Poorly correlated
-40.04%
UEEC - TDSGF
6%
Poorly correlated
-4.27%
More